I. Introduction
Hepatitis B Virus (HBV) infection remains a major public health problem worldwide. Immunization against hepatitis B virus (HBV) has proven to be highly effective and led to significant reduction of new infections worldwide. Italy was one of the first industrialized countries to introduce a program of universal vaccination against Hepatitis B virus (HBV) in 1991.Twenty years later, it was found that about 63% of subjects aged < 30 years were anti-HBs positive compared to about 25% in older subjects [1] . In present context even after adopting universal vaccination against Hepatitis B, the HBV infection is still not an uncommon problem leading to frequent hospitalization. The anti HBs status of children admitted in this hospital is not known amongst whom HBV vaccination could be advocated.
II. Objectives
To know the anti HBs status among children with chronic liver disease (CLD) attending Gastroenterology Department, Nehru Hospital, PGIMER, Chandigarh
III. Methodology
The study was carried out prospectively in a tertiary care hospital in North India. 
IV. Results
The mean age of eighty eight children included in the study was 7.8 yrs ± 3.9.These admitted CLD children were mostly of Wilson's disease, Chronic HCV infection, Budd Chiari Syndrome, Congenital Hepatic Fibrosis and Cirrhosis. Among these, 35 children with CLD (39.77%, 35/88 pts.) had nil level of anti HBs antibody with no history of vaccination against Hepatitis B Virus.12 children (13.63%,12/88 pts.) had anti HBs level of < 10 mIU/ml. Two among these children had history of incomplete vaccination against HBV. 13 children (14.77%, 13/88 pts.) had anti HBs level between 10 -50 mIU/ml. Another 10 children (11.36%, 10/88 pts.) had anti HBs titer between 50 -100 mIU/ml. Only 03 children (3.41%, 3/88 pts.) of CLD had anti HBs titer between 100-150 mIU/ml. Rest 15 Children ( 17.04%,15/88 pts.) had anti HBs titer > 150 mIU/ml (Table I.)These children had a history of complete vaccination against HBV. All patients were non reactive for anti HCV. Overall, 46.59% (41/88 ) children with chronic liver disease had sero-protective anti -HBs titer. 
V. Tables

VI. Discussion
Immunization against hepatitis B virus (HBV) has proven to be highly effective and has lead to significant reduction of new infections worldwide. After completion of immunization against HBV, the protective anti-HBs titers (≥10 mIU/ml) should be present in the children. However this protective sero-conversion does not occur uniformly. All patients admitted in hospital should undergo quantitative anti HBs ELISA and HBsAg ELISA evaluation in order to administer them HBV vaccine for future safety against HBV infection. Despite vaccination against HBV included in universal vaccination program, there were 39.77 % children (35/88 patients) who had undetectable level of anti HBs antibody. In present study 13.63% of CLD children(13/88 ) had anti HBs level which was not protective in nature with two patients having incomplete vaccination. A study of 107 healthy Egyptian children showed that 43 (40%) did not have a protective anti-HBs level (anti-HBs < 10 IU/L) and 64 (60%) had a protective level (anti-HBs ≥ 10 IU/L) [2] . In present study only 46.59% children (41/88 pts.) had sero-protective anti -HBs titer. However, protective immunity measured by anti-HBs titers may decrease to critical levels in the years after basal immunization, particularly in case of exposure to HBV variants different from the vaccine strain. At the age of one, 92.2% of the children presented with protective anti-HBs titers ( ≥10 mIU/ml) with the majority having ≥100 mIU/ml. Protective immunity was still high at ages 2 (87.5%) and 4 (95%), declining by age 5 and 6 (from 69.2% to 66.7%) and down to an average of 39.8% between the ages of 7 and 19 [3] .A retrospective study from children admitted in tertiary care hospital from Turkey showed the prevalence of sero-protective anti-HBs in 34.2% of children despite inclusion of vaccination against HBV in national vaccination programme [4] . A study from Yemen stated that coverage rate of HBV vaccine was only 69.9%. The response of vaccine in children was 54.8% ( 276/504 ) with anti-HBs antibody level ≥ 10 mIU/ml, while 228 (45.2%) of the 504 children had non-protective anti-HBs antibodies levels (<10IU/ml) [5] .But, in countries where vaccination against HBV is done with stringency shows that out of 98% children from Jeddah, kingdom of Saudi Arabia who received complete dosage of vaccination had protective anti HBs sero-positivity for anti HBs in 4 -6 yrs age group of 78.7% [6] .Hence in present scenario there is urgent need to vaccinate admitted children against HBV after evaluating anti HBs titers in order to protect them from HBV infection.
VII. Conclusion
46.59% children with chronic liver disease had sero-protective anti -HBs titer.39.77% children with chronic liver undergoing hospital treatment had undetectable anti-HBs antibody.These children were susceptible to Hepatitis B virus infection who urgently needed vaccination against HBV. Prophylactic vaccination against HBV infection should be advised in admitted patients after quantitative anti HBs testing.
